Tarsus Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Tarsus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Tarsus Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tarsus Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.7M | 63k | 59.43 |
| 2025-06-30 | $3.5M | 86k | 40.51 |
| 2025-03-31 | $3.7M | 71k | 51.37 |
| 2024-12-31 | $3.9M | 70k | 55.37 |
| 2024-09-30 | $1.9M | 59k | 32.89 |
| 2024-06-30 | $1.4M | 53k | 27.18 |
| 2024-03-31 | $826k | 23k | 36.35 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas